| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Gardner Jason is a See Remarks at Dianthus Therapeutics, Inc. /DE/. Recent SEC Form 4 filings include 1 buy and 8 sells.
Estimated insider holdings value: $24.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2021 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 14,340 | $6.73 | $96,508.20 | -4.8% | -27.5% | -75.5% | |
| Jan 10, 2020 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 11,200 | $15.25 | $170,800.00 | -4.3% | - | - | |
| Jan 2, 2020 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 2,800 | $15.10 | $42,280.00 | -1.1% | - | - | |
| Dec 23, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 2,897 | $15.10 | $43,754.55 | -1.1% | - | - | |
| Dec 20, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 76,711 | $15.16 | $1,162,616.57 | -22.2% | - | - | |
| Dec 10, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 4,392 | $15.10 | $66,319.20 | -1.3% | - | - | |
| Jun 21, 2019 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Sell | 14,000 | $15.11 | $211,523.31 | -1.9% | - | - | |
| Jun 25, 2018 | DNTH Dianthus Therapeutics, Inc. /de/ | See Remarks | Buy | 400 | $15.00 | $6,000.00 | +0.1% | - | - |